Daily BriefsThematic (Sector/Industry)

Daily Brief Thematic (Sector/Industry): The Impact of the US Biosecure Act on India’s Pharma Export Market and more

In today’s briefing:

  • The Impact of the US Biosecure Act on India’s Pharma Export Market
  • Earnings: TSMC, AEHR, ASML, VAT Group, Export Restrictions
  • Ohayo Japan | S&P 500 Surges in Tech-Led Rally
  • Union Budget 2024 Expectations: The Modi 3.0 Era and Its Impact on India’s Economic Growth
  • Mapping Indian Market Performance Around Past 10 Budgets
  • Japan Morning Connection – 22 July, 2024
  • Biopharma Week in Review – Jul 22, 2024
  • The Highlights – Cannabis News for the Week Ending July 19, 2024
  • Furniture/Furnishings Weekly – Another Good Week for Stocks


The Impact of the US Biosecure Act on India’s Pharma Export Market

By Nimish Maheshwari

  • The US Biosecure Act may restrict federal sourcing from China, boosting India’s pharmaceutical manufacturing.
  • India’s CDMO market is expected to double in three years, significantly enhancing global competitiveness.
  • Strategic investments in India’s pharmaceutical sector now appear more promising and potentially lucrative.

Earnings: TSMC, AEHR, ASML, VAT Group, Export Restrictions

By Douglas O’Laughlin

  • Aehr had a messy print, with the core business actually weaker than expected as they incorporated their recent acquisition. It’s hard to stay bearish, as they have a lot of potential product launches coming.

  • TSMC beat gross margins despite everything because of higher utilization. The logic cycle is starting to kick off in earnest. I believe WFE Capex will be much higher next year.

  • ASML talked up high-NA DRAM insertion on 25/26. Only Samsung could do it. Good luck, Samsung!


Ohayo Japan | S&P 500 Surges in Tech-Led Rally

By Mark Chadwick

  • Nvidia led the tech recovery, surging 4.8%, with Meta and Alphabet also posting strong gains.
  • Goodyear Tire & Rubber is selling its off-the-road equipment tire business to Yokohama Rubber for $905 million
  • Mitsubishi Heavy Industries has contracted with Airbus to supply emergency doors for A321neo planes, diversifying from its reliance on Boeing

Union Budget 2024 Expectations: The Modi 3.0 Era and Its Impact on India’s Economic Growth

By Nimish Maheshwari

  • The Union Budget 2024 expectations: Focuse on job creation, rural support, and domestic manufacturing, aiming to drive economic growth and self-reliance.
  • Employment, housing and Manufacturing will be the key priorities for Modi 3.O.
  • This Budget can see some Taxation benefits for middle-class salaried individuals by offering improved tax incentives and a simpler tax system.

Mapping Indian Market Performance Around Past 10 Budgets

By Sudarshan Bhandari

  • FM Nirmala Sitharaman prepares to unveil the Union Budget for the fiscal year 2024-25 on July 23rd.
  • Movement of Sensex and Nifty around the Budget day and post that.
  • What sectors performed best and worst during the last 10 budget days?

Japan Morning Connection – 22 July, 2024

By Andrew Jackson

  • Markets fell with Russell -0.63%, SPX -0.71%, Nasdaq -0.93% and SOX -3.11%. UST10 rose 0.88% and the yen weakened to Y157.48. Commodoties fell.
  • CRWD -11.1%, MSFT -0.74%, and power semis (Wolfspeed -7.17%) fell due to a CrowdStrike IT outage and Trump-related EV concerns respectively, showing sector vulnerability.
  • Stocks with China exposure fell sharply due to US export restrictions, with Disco -23.1%, TEL -18.1%, Screen -17.8%. Intuitive Surgical surged on strong Q2 results and da Vinci 5 launch.

Biopharma Week in Review – Jul 22, 2024

By Water Tower Research

  • We review last week’s biopharma news for meaningful clinical data, regulatory updates, research innovation, and M&A.
  • Roche Holding Ltd. (RHHBY) reported initial Phase 1 data for oral GLP-1R agonist CT-996 in obesity patients, showing a 6.1% placebo-adjusted weight loss (p<0.001) at four weeks.
  • While the weight loss compares favorably with approved injectables at four weeks (1-3% adjusted), the lack of details in the CT996 data, like baseline body weight, limits any cross-trial comparison. 

The Highlights – Cannabis News for the Week Ending July 19, 2024

By Water Tower Research

  • Cannabis stocks started strong last week but faded on Friday. MSOS dropped 2.50% over the five sessions, while YOLO fell 1.73%.
  • Ascend (CSE: AAWH, OTCQX: AAWH) rallied 12.18% following its debt refinancing, while Jushi (CSE: JUSH, OTCQX: JUSHF) lost the most at -9.84%.
  • Ascend (CSE: AAWH, OTCQX: AAWH) announced on Monday it successfully refinanced its debt.

Furniture/Furnishings Weekly – Another Good Week for Stocks

By Water Tower Research

  • Rotation into smaller-cap and value stocks continues.
  • The Water Tower Research Commercial/Contract Index (+1.2%) and Residential Manufacturers & Suppliers Index (+2.4%) benefited, while the Home Goods Retailers Index (-2.1%) was weighed down, in part, by bankruptcy concerns for CONN.
  • The Mass Retailers Index (-2.4%) was affected by weakness in growth stocks, giant caps, and technology components of the market. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars